Reeves Gordon R, Whellan David J, O'Connor Christopher M, Duncan Pamela, Eggebeen Joel D, Morgan Timothy M, Hewston Leigh Ann, Pastva Amy, Patel Mahesh J, Kitzman Dalane W
Department of Medicine, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania.
Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
JACC Heart Fail. 2017 May;5(5):359-366. doi: 10.1016/j.jchf.2016.12.019. Epub 2017 Mar 8.
This study sought to assess a novel physical rehabilitation intervention in older patients hospitalized for acute decompensated heart failure (ADHF).
After ADHF, older patients, who are frequently frail with multiple comorbidities, have prolonged and incomplete recovery of physical function and remain at high risk for poor outcomes.
The REHAB-HF (Rehabilitation Therapy in Older Acute Heart Failure Patients) pilot study was a 3-site, randomized, attention-controlled pilot study of a tailored, progressive, multidomain physical rehabilitation intervention beginning in the hospital and continuing for 12 weeks post-discharge in patients ≥60 years hospitalized with ADHF. The primary purpose was to assess the feasibility and reasonableness of the hypothesis that the novel rehabilitation intervention would improve physical function (Short Physical Performance Battery [SPPB]) over 3 months and reduce all-cause rehospitalizations over 6 months.
The study enrolled 27 patients with ADHF (ages 60 to 98 years; 59% women; 56% African American; 41% with preserved ejection fraction [≥45%]). At baseline, participants had marked impairments in physical function, multiple comorbidities, and frailty. Study retention (89%) and intervention adherence (93%) were excellent. At 3 months, an intervention effect size was measured for the SPPB score of +1.1 U (7.4 ± 0.5 U vs. 6.3 ± 0.5 U), and at 6 months an effect size was observed for an all-cause rehospitalization rate of -0.48 (1.16 ± 0.35 vs. 1.64 ± 0.39). The change in SPPB score was strongly related to all-cause rehospitalizations, explaining 91% of change.
These findings support the feasibility and rationale for a recently launched, National Institutes of Health-funded trial to test the safety and efficacy of this novel multidomain physical rehabilitation intervention to improve physical function and reduce rehospitalizations in older, frail patients with ADHF with multiple comorbidities. (Rehabilitation and Exercise Training After Hospitalization [REHAB-HF]; NCT01508650; A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients [REHAB-HF]; NCT02196038).
本研究旨在评估一种针对因急性失代偿性心力衰竭(ADHF)住院的老年患者的新型物理康复干预措施。
ADHF发作后,老年患者往往身体虚弱且伴有多种合并症,身体功能恢复时间延长且不完全,不良结局风险仍然很高。
REHAB-HF(老年急性心力衰竭患者康复治疗)试点研究是一项在3个地点开展的随机、注意力对照试点研究,针对≥60岁因ADHF住院的患者,采用量身定制的、渐进的、多领域物理康复干预措施,从住院开始并在出院后持续12周。主要目的是评估以下假设的可行性和合理性:这种新型康复干预措施将在3个月内改善身体功能(简短身体功能量表[SPPB]),并在6个月内降低全因再住院率。
该研究纳入了27例ADHF患者(年龄60至98岁;59%为女性;56%为非裔美国人;41%射血分数保留[≥45%])。基线时,参与者身体功能存在明显损害,伴有多种合并症且身体虚弱。研究保留率(89%)和干预依从性(93%)都很高。3个月时,SPPB评分的干预效应量为+1.1 U(7.4±0.5 U对6.3±0.5 U),6个月时,全因再住院率的效应量为-0.48(1.16±0.35对1.64±0.39)。SPPB评分的变化与全因再住院率密切相关,可解释91%的变化。
这些发现支持了最近由美国国立卫生研究院资助开展的一项试验的可行性和基本原理,该试验旨在测试这种新型多领域物理康复干预措施对改善身体功能和降低患有多种合并症的老年体弱ADHF患者再住院率的安全性和有效性。(住院后康复与运动训练[REHAB-HF];NCT01508650;老年急性心力衰竭患者康复治疗试验[REHAB-HF];NCT02196038)